Zdrowie i gospodarka · 07/09/2017

FDA Announces Final Guidance on Deviation Reporting for Human Cells, Tissues, and Cellular and Tissue-Based Products

The FDA has released a final guidance document providing recommendations and examples for establishments manufacturing non-reproductive human cells, tissues, and products to comply with deviation reporting requirements under the Public Health Service Act and FDA regulations.